Implementing a Screening Tool for Identifying Patients at Risk for Hereditary Breast and Ovarian Cancer: A Statewide Initiative

Annals of Surgical Oncology

Volumn 21, Issue 10, 2014, Pages 3342-3347

  Brannon Traxler, L ^a   Martin, Monique L ^b   Kerber, Alice S ^b   Bellcross, Cecelia A ^a   Crane, Barbara E ^c   Green, Victoria ^d   Matthews, Roland ^e   Paris, Nancy M ^b   Gabram, Sheryl G A ^a,f  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Georgia Center for Oncology Research and Education   (United States)

^c GEORGIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^d EMORY UNIVERSITY   (United States)

^e MOREHOUSE SCHOOL OF MEDICINE   (United States)

^f GRADY MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA1 PROTEIN, HUMAN; BRCA2 PROTEIN; BRCA2 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; HEALTH CARE PLANNING; HUMAN; LEGISLATION AND JURISPRUDENCE; MALE; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; PROGNOSIS; PUBLIC HEALTH; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HEALTH PLAN IMPLEMENTATION; HUMANS; MALE; MIDDLE AGED; MUTATION; NATIONAL HEALTH PROGRAMS; OVARIAN NEOPLASMS; PROGNOSIS; UNITED STATES; YOUNG ADULT;

EID: 84930972495     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-3921-1     Document Type: Article

References (13)

1. U.S. Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med. 2005;143:355–61.
2. Berry DA, Iversen ES Jr, Gudbjartsson DR, Hiller EH, Garber JE, Peshkin BN, et al. BRACPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol. 2002;20:2701–12.
3. Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med. 2004;23:1111–30.
4. Antoniou AC, Pharoah PP, Smith P, Easton DF. The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer. 2004;91:1580–90.
5. Teller P, Hoskins KF, Zwaagstra A, Stanislaw C, Iyengar R, Green VL, et al. Validation of the Pedigree Assessment Tool (PAT) in families with BRCA1 and BRCA2 mutations. Ann Surg Oncol. 2010;17:240–6.
6. Moyer VA on behalf of the U.S. Preventive Services Task Force. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160:271–81.
7. Bellcross CA, Lemke AA, Pape LS, Tess AL, Meisner LT. Evaluation of a breast/ovarian cancer genetics referral screening tool in a mammography population. Genet Med. 2009;11:783–9.
8. Bellcross CA. Further development and evaluation of a breast/ovarian cancer genetics referral screening tool. Genet Med. 2010;12:240.
9. Thompson HS, Sussner K, Schwartz MD, Edwards T, Forman A, Jandorf L, et al. Receipt of genetic counseling recommendations among black women at high risk for BRCA mutations. Genet Test Mol Biomarkers. 2012;16:1257–62.
10. Sheppard VB, Mays D, LaVeist T, Tercyak KP. Medical mistrust influences black women’s level of engagement in BRCA1/2 genetic counseling and testing. J Natl Med Assoc. 2013;105:17–22.
11. Thompson HS, Valdimarsdottir HB, Duteau-Buck C, Guevarra J, Bovbjerg DH, Richmond-Avellaneda C, et al. Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women. Cancer Epidem Biomarkers. 2002;11:1579–85.
12. Armstrong K, Micco E, Carney A, Stopfer J, Putt M. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA. 2005;293:1729–36.
13. Centers for Disease Control and Prevention. CDC awards programmatic funding to support breast cancer genomics. http://www.cdc.gov/cancer/breast/what_cdc_is_doing/genomics_foa.htm (2013). Accessed 17 March 2014.